Literature DB >> 8246579

Cardiopulmonary bypass significantly reduces surfactant activity in children.

F X McGowan1, M Ikegami, P J del Nido, E K Motoyama, G Kurland, P J Davis, R D Siewers.   

Abstract

Lung injury remains an important problem after cardiopulmonary bypass. The contribution of altered surfactant concentration or activity to pulmonary dysfunction after cardiopulmonary bypass is unclear. Recent evidence indicates that alveolar surfactant exists in specific aggregate forms that differ with respect to density, phospholipid composition, and function. A transition from surface active, higher density, large aggregates of surfactant to lower density, small aggregates that possess reduced surface activity has been demonstrated after experimental lung injury. The purpose of the present study was to examine surfactant aggregate fractions before and after bypass in children. Twelve acyanotic patients, aged 2 to 12 years, underwent intraoperative pulmonary function testing followed by bronchoalveolar lavage before incision and approximately 1 hour after termination of cardiopulmonary bypass. Saturated phosphatidylcholine pool sizes and total protein content of the small- and large-aggregate fractions of bronchoalveolar lavage fluid were determined. One hour after termination of cardiopulmonary bypass, the ratio of saturated phosphatidylcholine in small-aggregate as compared with that in large-aggregate fractions increased (mean +/- standard error) from 0.19 +/- 0.03 to 0.37 +/- 0.07 (p < 0.02), as did the ratio of saturated phosphatidylcholine to protein in the small-aggregate fraction (from 0.04 +/- 0.01 to 0.08 +/- 0.02, p < 0.05). Reductions in forced vital capacity (-19% +/- 5%), inspiratory capacity (-15% +/- 3%), and small airway flow rates (-32% +/- 6%) were also observed after bypass. These changes were accompanied by a fivefold increase in alveolar polymorphonuclear leukocyte content. The present study suggests that cardiopulmonary bypass of moderate duration in relatively healthy children is associated with surfactant changes that are similar in type and magnitude to those observed in experimental lung injury.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8246579

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  6 in total

Review 1.  Mechanical cardiopulmonary support in children and young adults: extracorporeal membrane oxygenation, ventricular assist devices, and long-term support devices.

Authors:  A C Chang; E D McKenzie
Journal:  Pediatr Cardiol       Date:  2005 Jan-Feb       Impact factor: 1.655

Review 2.  Pump or no pump for coronary artery bypass: current best available evidence.

Authors:  Shahzad G Raja
Journal:  Tex Heart Inst J       Date:  2005

3.  Surfactant treatment for acute respiratory distress syndrome.

Authors:  J López-Herce; N de Lucas; A Carrillo; A Bustinza; R Moral
Journal:  Arch Dis Child       Date:  1999-03       Impact factor: 3.791

4.  Surfactant Administration During Pediatric Extracorporeal Membrane Oxygenation.

Authors:  Steven L Shein; Timothy M Maul; Hong Li; Geoffrey Kurland
Journal:  ASAIO J       Date:  2015 Nov-Dec       Impact factor: 2.872

Review 5.  Off-pump coronary artery bypass grafting in octogenarians.

Authors:  Shahzad G Raja
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

6.  Intravenous loading of nitroglycerin during rewarming of cardiopulmonary bypass improves metabolic homeostasis in cardiac surgery: a retrospective analysis.

Authors:  Ying-Hsuan Tai; Kuang-Yi Chang; Shu-Wei Liao; Kwei-Chun Chung; Chun-Che Shih; Shung-Tai Ho; Chih-Cherng Lu; Mei-Yung Tsou
Journal:  J Anesth       Date:  2016-06-22       Impact factor: 2.078

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.